Bitcoin continues to consolidate near record highs above $109,000. The market's enthusiasm is driven by Bitcoin's growing popularity among institutions and businesses. However, retail investor engagement remains at historically low levels.
The Bitcoin and broader cryptocurrency market is undergoing a new wave of institutional adoption and growing geopolitical relevance. MicroStrategy continues its aggressive accumulation strategy, now holding 580,250 BTC—nearly 2.8% of total supply—after its latest $427 million purchase. This move pushed the company's unrealized profits to over $22.7 billion. Meanwhile, other companies like The Blockchain Group and DDC Enterprise are also boosting their crypto holdings, with weekly capital inflows into ETFs reaching an impressive $2.9 billion.
Adoption and regulatory developments are also shaping the market. Thailand plans to allow tourists to spend crypto directly via linked credit cards, while Dubai is set to tokenize real estate worth $16 billion on the XRP blockchain.
On the flip side, regulatory uncertainty persists in areas like staking. U.S. banks are reportedly exploring the joint issuance of a stablecoin, which would likely be enabled by a new law under discussion. This represents further integration of traditional finance with DeFi technologies.
Yesterday, political headlines were stirred by reports of a new strategy from Trump’s company—Trump Media and Technology Group (DJT.US). The firm announced a $2.5 billion private stock offering to 50 institutional investors, aiming to create one of the largest Bitcoin treasuries among publicly traded companies. In response, Bitcoin's price briefly spiked to nearly $111,000 before retreating below $110,000.
Daily Summary: U.S. stock indices are climbing following the PPI data
US OPEN: Wall Street Rallies on Soft PPI Data
BREAKING: US PPI comes in weaker than expected. EURUSD gains ground
JP Morgan earnings: Good, but it could have been better
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.